isobarbaloin has been researched along with alloin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jo, AR; Kim, JH; Kim, YH; Li, W; Sun, YN; Yan, XT; Yang, SY | 1 |
| Hu, Y; Jadhav, P; Tan, B; Tan, H; Wang, J | 1 |
1 review(s) available for isobarbaloin and alloin
| Article | Year |
|---|---|
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease.
Topics: Antiviral Agents; Coronavirus Papain-Like Proteases; COVID-19 Drug Treatment; Humans; Pandemics; Protease Inhibitors; SARS-CoV-2 | 2022 |
1 other study(ies) available for isobarbaloin and alloin
| Article | Year |
|---|---|
Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe.
Topics: Aloe; Anthraquinones; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoxide Hydrolases; Molecular Structure; Solubility; Structure-Activity Relationship | 2015 |